Beta Bionics (NASDAQ:BBNX) Upgraded at Baird R W

Baird R W upgraded shares of Beta Bionics (NASDAQ:BBNX) to a hold rating in a report released on Thursday morning,Zacks.com reports.

Other analysts have also recently issued reports about the stock. Robert W. Baird assumed coverage on shares of Beta Bionics in a report on Thursday. They set a “neutral” rating and a $20.00 target price for the company. LADENBURG THALM/SH SH assumed coverage on shares of Beta Bionics in a report on Thursday. They set a “neutral” rating and a $20.00 target price for the company.

Beta Bionics Stock Down 1.4 %

Shares of NASDAQ:BBNX opened at $20.57 on Thursday. Beta Bionics has a 1-year low of $20.57 and a 1-year high of $24.50.

Insider Buying and Selling

In other news, insider Mike Mensinger acquired 33,350 shares of the firm’s stock in a transaction that occurred on Friday, January 31st. The stock was purchased at an average price of $17.00 per share, with a total value of $566,950.00. Following the purchase, the insider now owns 59,019 shares of the company’s stock, valued at approximately $1,003,323. This trade represents a 129.92 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, major shareholder Hadley Harbor Aggre Wellington acquired 1,000,000 shares of the firm’s stock in a transaction that occurred on Friday, January 31st. The stock was purchased at an average cost of $17.00 per share, with a total value of $17,000,000.00. Following the purchase, the insider now directly owns 3,901,599 shares in the company, valued at approximately $66,327,183. This trade represents a 34.46 % increase in their position. The disclosure for this purchase can be found here.

Beta Bionics Company Profile

Beta Bionics, Inc is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.